CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) stock declines while market improves: Some information for ...
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.21, marking a -4.71% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.26%. At the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈